Erik Gerson

Erik Gerson has a diverse range of work experience in the scientific research field. Erik is currently working as a Senior Research Associate at Marengo Therapeutics since March 2023. Prior to this, they held the same position at Synlogic, Inc., from November 2020 to December 2022. Erik also worked as a Research Associate at Blueprint Medicines from November 2019 to November 2020, and at Rheos Medicines, Inc. from April 2018 to August 2019. Erik started their career as a Research Associate at Selecta Biosciences from November 2017 to March 2018. Erik gained experience as a temporary Research Technician at Harvard T.H. Chan School of Public Health from July 2017 to October 2017, where they conducted ELISA experiments to assess protein content in plasma samples. Prior to that, they worked as a Data Researcher at Infinata from August 2016 to April 2017, focusing on acquiring information about drug pipelines. Additionally, Erik has experience in undergraduate toxicology research at the University of Maine, where they held positions as an Undergraduate Toxicology Researcher from September 2014 to May 2016 and as a Student Research Assistant from June 2015 to August 2015. Lastly, they have past experience in non-research roles, including Reception/Information Desk at Betty Doon Hotel and Lights Operator at Booth Theater, both from May 2013 to August 2014. Overall, Erik's work experience demonstrates their expertise in scientific research and their ability to adapt to different environments.

Erik Gerson holds a Bachelor of Science (B.S.) degree in Biochemistry from the University of Maine. The duration of their education is not provided.